BÜHLMANN fCAL® turbo
Speed, Quality and Flexibility in Calprotectin Quantification
BUHLMANN Diagnostics Corp (BDC), BÜHLMANN Laboratories AG’s North American affiliate is proud to announce that its innovative product, BÜHLMANN fCAL® turbo, has received a Medical Device License from Health Canada and is now commercially available in Canada. The device was approved as a Class 2 medical device according to the Canadian Medical Device Regulations. Read More
- Random access
- Fast results: 10 min
- Flexible: applicable on all major clinical chemistry analyzers
Health Canada License: 96808
BÜHLMANN fCAL® turbo is Research Use Only in the US.